Transcatheter heart valves technologies

Pacemaker Implantation for Low‐Grade Conduction Abnormalities After Balloon‐Expandable Transcatheter Aortic Valve Implantation

Published on 21/11/2024 | Julian Wolfes 1 et al. | Clinical Cardiology 2024; 47(11): 70028 | 15 minute read

Abstract Introduction A frequent complication after TAVI are postinterventional conduction abnormalities requiring permanent pacemaker implantation. In this study, we analyzed

Transcatheter heart valves technologies

Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial

Published on 07/11/2024 | Tobias Rheude et al. | European Heart Journal 2024; aop: 10.1093/eurheartj/ehae784 | 0 minute read

Transcatheter heart valves technologies

Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement

Published on 07/11/2024 | WenceShiMD et al. | Journal of the American Heart Association 2024; 13(21): 035597 | 24 minute read

Abstract Background The mechanism for hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve replacement is still not well elucidated, and

Transcatheter heart valves technologies

Successful management of acute left main coronary occlusion following transcatheter aortic valve implantation: a case report

Published on 17/10/2024 | Goranov Georgi 1 et al. | Journal of Medical Case Reports 2024; 18(1): 477 | 8 minute read

Abstract Background Transcatheter aortic valve implantation is an established, highly effective procedure in selected patients with severe degenerative aortic valve

Transcatheter heart valves technologies

Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new‐generation devices: Insights from the LAPLACE‐TAVI registry

Published on 17/10/2024 | Motoki FukutomiMD et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31261 | 18 minute read

Abstract Background A history of hospitalization for heart failure (HHF) before transcatheter aortic valve implantation (TAVI) or surgical aortic valve

Transcatheter heart valves technologies

Recovery rate from conduction disorders in patients with permanent pacemaker implantation after transcatheter aortic valve implantation

Published on 03/10/2024 | Maria Yamamoto 1 et al. | Open Heart 2024; 11(2): e002867 | 14 minute read

Abstract Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aortic valve implantation (TAVI). To seek

$Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement$

Transcatheter heart valves technologies

Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement

Published on 03/10/2024 | Mehmet CilingirogluMD 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31252 | 4 minute read

Abstract Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic

Transcatheter heart valves technologies

The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis

Published on 19/09/2024 | Puck J. A.vanNuland 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31218 | 22 minute read

Abstract Background Bleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these

Transcatheter heart valves technologies

Difference in Cardiac Response after Transcatheter Aortic Valve Implantation according to Flow and Gradient Pattern

Published on 19/09/2024 | Hiroaki Yokoyama et al. | European heart journal cardiovascular Imaging 2024; aop: 10.1093/ehjci/jeae235 | 0 minute read

Transcatheter heart valves technologies

Hypercapnia during transcatheter aortic valve replacement under monitored anaesthesia care: a retrospective cohort study

Published on 05/09/2024 | Tzonghuei Chen 1 et al. | Open Heart 2024; 11(2): e002801 | 31 minute read

Abstract Background Acute intraoperative hypercapnia and respiratory acidosis, which can occur during monitored anaesthesia care (MAC), pose significant cardiopulmonary risks

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.